Nebraska Oncology Society
Avatar

ASCO 2022 on Moving Toward a Cure in Myeloma: The Role of MRD Testing

By Nebraska Oncology Society FEATURING Ajay Nooka
July 7, 2022
2 Comments
Login to view comments. Click here to Login

Featured Video

06:56
Sanofi

Autologous HCT in Older Adults with MM: Eligibility Assessment

Feat. T. Wildes

Featured Video

19:41
Merck Oncology

Discussion on a Potential Treatment Option for Certain Adult Patient…

Feat. J. Kuruvilla

Related Content

AUTOPLAY
15:54
Paul Richardson

Emerging Strategies in the Management of Relapsed MM

12:38
SOHO 2022 Tenth Annual Meeting

SOHO 2022 DEBATE: Bispecific Antibodies vs. CAR-T for R/R MM - Defen…

Feat. S. Usmani
21:38
Rahul Banerjee

CAR-T Therapy in Myeloma: What's Here and What's Coming So…

09:09
Douglas W. Sborov

IMS 2022 Final Analysis of the GRIFFIN Trial: Daratumumab + Lenalido…

06:41
Hamza Hashmi

Idecabtagene Vicleucel vs. Ciltacabtagene Autoleucel: A Sophie'…

33:28
Cleveland Clinic Taussig Cancer Institute

Management of Relapsed/Refractory Multiple Myeloma

Feat. F. Anwer
34:28
2022 Community Oncology Conference

Treatment Conundrums in Myeloma

Feat. S. Giralt
21:16
UChicago Medicine

Myeloma 2022: Challenges and Path Forward

Feat. A. Jakubowiak
Shambavi Richard

Updates in Sequencing Treatment for Early Multiple Myeloma Relapse

24:19
Dana-Farber Cancer Institute

Phase 3 DETERMINATION Trial: RVd ± ASCT & Lenalidomide Maintenan…

Feat. P. Richardson
30:59
Houston Methodist Hospital

Overview of Advances in Multiple Myeloma

Feat. S. Ganguly
19:48
Penn Medicine Abramson Cancer Center

New Therapies for Relapsed Myeloma

Feat. D. Vogl
20:31
Ambuga Badari

Management of Multiple Myeloma in First Relapse

12:09
Dana-Farber Cancer Institute

2022 Treatment Landscape and Future Directions of R/R Multiple Myelo…

Feat. N. Munshi
10:51
Peter Voorhees

IMS 2022 on Updated Results of a Phase 1, First-in-Human Study of AB…

08:49
The Ohio State University - Wexner Medical Center

2022 Updates on the Treatment of Early R/R Multiple Myeloma

Feat. A. Khan
10:29
Mary Kwok

Moving to Quadruplets in NDMM

11:29
ASCO 2022 Conference Coverage

ASCO 2022 on the Addition of Carfilzomib as a Third Agent in Lenalid…

Feat. C. Cerchione
45:43
MedNews Week

Multiple Myeloma in 2022: Developments, Directions, and Disparities

Feat. J. Mikhael
13:12
ASH 2021 Conference Coverage on VuMedi

ASH 2021: Addressing Current Questions and Controversies in the Mana…

Feat. M. Gertz